1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
(
- Contribution to journal › Scientific review
- 2013
-
Mark
AC-186, a Selective Nonsteroidal Estrogen Receptor beta Agonist, Shows Gender Specific Neuroprotection in a Parkinson's Disease Rat Model
(
- Contribution to journal › Article
-
Mark
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
(
- Contribution to journal › Article
- 2010
-
Mark
Optimization of isochromanone based urotensin II receptor agonists
(
- Contribution to journal › Article
- 2009
-
Mark
Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis
(
- Contribution to journal › Article
- 2008
-
Mark
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist
(
- Contribution to journal › Article
- 2004
-
Mark
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine
(
- Contribution to journal › Article